-+ 0.00%
-+ 0.00%
-+ 0.00%

FDA Grants Breakthrough Therapy Designation to Praxis Precision Medicines' Ulixacaltamide for Essential Tremor

Reuters·12/29/2025 13:00:12

Please log in to view news